12.07.2022 - 14.07.2022Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 08:00 - 17:30
Temas de la conferencia Join the In Vivo Engineering of Therapeutic Cells Summit to Discover the Future of Cell and Gene Therapy!
In vivo gene engineering is fast becoming known as the future of cell and gene therapy with incredible amounts of investment seen in 2021, including the recent Moderna and Metagenomi collaboration alongside the partnership between Abintus Bio and MSKCC, and Tidal acquisition by Sanofi.
Organizador profesional (PCO) Hanson Wade
Observaciones Speakers: Adrian Bot, Chief Scientific Officer and Executive Vice President of R and D, Capstan Therapeutics, Andy Scharenberg, Chief Executive Officer, Umoja Biopharma, Cory Bentley, Co-Founder & Senior Vice President of R and D, Abintus Bio & more.
Información e inscripción:
https://go.evvnt.com/1038825-1?pid=4832
Mr. In Vivo Engineering of Therapeutic Cells Summit
Cuota del Congreso Drug Developers (Earlybird rates and workshops available): USD 2999.0,
Academic (Earlybird rates and workshops available): USD 2599.0,
Service Providers (Earlybird rates and workshops available): USD 3599.0
Cantacto organizador 83 Great Titchfield Street W1W 6RH London United Kingdom
